Image of logo for Medications and nutrition and is sited in the header and footer
  • Membership Options
  • MedNut Mail
  • Resources
  • Contact Us
  • Login
  • Home
  • |
  • Archives: PharmacoNutrition

PharmacoNutrition

The interface between prescribed medicines and nutritional factors is so overlooked that it is commonly referred to as drug-nutrient interactions and/or drug-food interactions.

Clinical category

PharmacoNutrition as a suitable name as it encompasses the broad scope of the field including both direct and indirect drug-food and drug-nutrient interactions. Those conducting research in this field would be Pharmaco-nutrologists.

Primary contributors to clinical exclusion

Research aspects

Research papers are scattered across a plethora of journals and subjects. The studies are mostly small.

Assumptions - for which there is no evidence

Food intake will cover the drug-induced nutrient losses. Food is benign and unlikely to interact with pharmaceuticals.

Health professional training

The training for doctors, pharmacists, and most other health professionals does not include a significant nutrition component. This is surprising given 80+% of western ill-health has an underlying negative nutrition component.

Who will fund and conduct the research?

Pharmaceutical industry

The regulatory processes do not require negative nutritional impacts of pharmaceutical products to be included in the drug discovery process.

Governmental research bodies

The number of similarly worthwhile research projects competing for funding is steadily increasing whilst the funding sources and are generally not increasing.

Philanthropic bodies

Philanthropic bodies either support a specific area of research or dispense smaller grants to a larger number of applicants. Sadly, there aren’t any philanthropic bodies with a particular interest in this area of expertise.

Medications & Nutrition Platform

The online platform Medications & Nutrition provides a comprehensive range of clinically-useful, referenced, research evidence that is presented in a dot point format to improve accessibility to the latest research for busy clinicians. Examples of integration formats are included in the Case study component of our MedNut Mail series.

December 5, 2022

0  comments

DOACs and pharmaconutrition

​DOACs (direct oral anticoagulants) are becoming the preferred option for coagulation management because they do not require the management strategies ...

Read More

November 7, 2022

0  comments

Drug interactions and pharmaconutrition

Mechanisms and consequences  Medications, medicines, drugs are used interchangeably to describe chemical substances that are administered to confer therapeutic benefit; ...

Read More

November 2, 2022

0  comments

Acid-base balance and pharmaconutrition

​Acid-base imbalance is now being associated with a range of Western health disorders including insulin resistance, diabetes, thyroid function resistance, ...

Read More

October 24, 2022

0  comments

Steady state and pharmaconutrition

​Steady state concentration is the period during which the therapeutic levels remain constant. It is achieved when a defined amount ...

Read More

October 17, 2022

0  comments

Non-insulin diabetes preparations and pharmaconutrition

Mechanisms and consequences  I now understand why duration of therapeutic effect of the non-insulin diabetes drugs is not an integral ...

Read More

October 10, 2022

0  comments

Insulin resistance and pharmaconutrition

​Insulin resistance is defined as a lack of cellular response to insulin – likely due to closed, damaged or insufficient ...

Read More

October 4, 2022

0  comments

Insulin and pharmaconutrition

​Insulin is a highly effective anabolic hormone that is primarily produced in the pancreas, and small amounts are also produced ...

Read More

September 27, 2022

0  comments

Harm minimisation and pharmaconutrition

Mechanisms and consequences  Supported by policies, practices and programs, harm minimisation is essentially a philosophy, in a range of sectors, ...

Read More

September 20, 2022

0  comments

Denosumab and nutrition

Mechanisms and consequences  Denosumab is prescribed for the treatment of bone loss in adults at high risk of bone fractures. ...

Read More

September 15, 2022

0  comments

Bone health and pharmaconutrition

​Bone health is so important and so overlooked and is usually only considered once there is a problem.  Mechanisms and ...

Read More

September 8, 2022

0  comments

Guest case study – an innocuous combination of prescribed medications

Guest case study  A reader sent in this list of prescribed medications and did not provide any other information. Drug-food ...

Read More

July 25, 2022

0  comments

Some neuroinflammation markers and pharmaconutrition

​Neuroinflammation occurs when the brain’s innate immune system is challenged by factors such as injury, infection, toxin exposure, or neurodegeneration, ...

Read More

July 19, 2022

0  comments

Costs of inaction

​Costs of inaction is a term typically associated with business decisions. What are the costs if you choose not to ...

Read More

July 12, 2022

0  comments

AcetylCoA and aspirin

​Pantothenate is important in many basic physiological functions, and especially as a precursor for Coenzyme A also known as CoA ...

Read More

June 29, 2022

0  comments

Astrocytes and pharmaconutrition

Mechanisms and consequences  Astrocytes are overlooked essential intermediaries in neurological physiology. Astrocytes operate on a network system whereby they service ...

Read More

June 15, 2022

0  comments

Pyridoxine and pharmaconutrition

Mechanisms and consequences  Pyridoxine (Vitamin B6) is important in many body functions and is seemingly now becoming “sexy” to some ...

Read More

June 8, 2022

0  comments

Templates for common clinical observations 5

Time-saving templates  Templates are useful for ensuring essential information is passed on without any aspect being overlooked as they can ...

Read More

June 1, 2022

0  comments

Pantothenate and pharmaconutrition

​Pantothenate is a nutrient that is very out-of-sight and out-of-mind – is there, or should there be, a pharmaconutrition concern?  ...

Read More

May 24, 2022

0  comments

Food industry and pharmaconutrition

Mechanisms and consequences  The combination of identification of physiological transporters and their potential for accessing currently inaccessible-for-pharmaceuticals parts of the ...

Read More

May 3, 2022

0  comments

B6 absorption requires an acid environment

Mechanisms and consequences  A recent seminal study (https://doi.org/10.1074/jbc.RA120.013610) found that ThTr1/2 (Thiamine Transporters 1/2) can transport both thiamine and pyridoxine ...

Read More
Load More
Image of logo for Medications and nutrition and is sited in the header and footer
  • Home
  • About
  • Contact Us
  • Login
  • Membership Options
  • Resources
  • Mednut Mail
  • Editorial policy
  • Privacy Policy
  • Terms of Use
  • Product Expectations Agreement
Image of icon for LinkedIn
Image of YouTube for footer of medications and nutrition website

We acknowledge the Aboriginal and Torres Strait Islander people as the Traditional Custodians of Country, and acknowledge and pay our respects to their Elders past, present and emerging.

ABN: 56 191 983 404            © Copyright 2025. All rights reserved.

Malcare WordPress Security